Clinical Trial Update: Insulin Glulisine, Diabetes Mellitus Type 1 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating insulin glulisine for type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED